EMEA (Europe, Middle East and Africa) Ophthalmology Drugs Industry 2017 Market Research Report

Published: Nov, 2017 | Pages: 109 | Publisher: QYResearch
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

In this report, the EMEA Ophthalmology Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Pcs), revenue (Million USD), market share and growth rate of Ophthalmology Drugs for these regions, from 2012 to 2022 (forecast)
    Europe: Germany, France, UK, Russia, Italy and Benelux;
    Middle East: Saudi Arabia, Israel, UAE and Iran;
    Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Ophthalmology Drugs market competition by top manufacturers/players, with Ophthalmology Drugs sales volume (K Pcs), price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including
    Novartis
    Regeneron
    Roche
    Bayer
    Allergan
    Shire
    Mallinckrodt
    ...

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
    Lucentis (ranibizumab)
    Eylea (aflibercept)
    Avastin (bevacizumab)
    Restasis (cyclosporine)
    Alphagan (brimonidine tartrate)
    Lumigan (bimatoprost)
    Xalatan (latanoprost

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Chorioretinitis
    Choroiditis
    Retinitis
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 Table of Contents

EMEA (Europe, Middle East and Africa) Ophthalmology Drugs Market Report 2017
1 Ophthalmology Drugs Overview
    1.1 Product Overview and Scope of Ophthalmology Drugs
    1.2 Classification of Ophthalmology Drugs
        1.2.1 EMEA Ophthalmology Drugs Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 EMEA Ophthalmology Drugs Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Lucentis (ranibizumab)
        1.2.4 Eylea (aflibercept)
        1.2.5 Avastin (bevacizumab)
        1.2.6 Restasis (cyclosporine)
        1.2.7 Alphagan (brimonidine tartrate)
        1.2.8 Lumigan (bimatoprost)
        1.2.9 Xalatan (latanoprost
    1.3 EMEA Ophthalmology Drugs Market by Application/End Users
        1.3.1 EMEA Ophthalmology Drugs Sales (Volume) and Market Share Comparison by Application (2012-2022
        1.3.2 Chorioretinitis
        1.3.3 Choroiditis
        1.3.4 Retinitis
        1.3.5 Others
    1.4 EMEA Ophthalmology Drugs Market by Region
        1.4.1 EMEA Ophthalmology Drugs Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 Europe Status and Prospect (2012-2022)
        1.4.3 Middle East Status and Prospect (2012-2022)
        1.4.4 Africa Status and Prospect (2012-2022)
    1.5 EMEA Market Size (Value and Volume) of Ophthalmology Drugs (2012-2022)
        1.5.1 EMEA Ophthalmology Drugs Sales and Growth Rate (2012-2022)
        1.5.2 EMEA Ophthalmology Drugs Revenue and Growth Rate (2012-2022)

2 EMEA Ophthalmology Drugs Competition by Manufacturers/Players/Suppliers, Region, Type and Application
    2.1 EMEA Ophthalmology Drugs Market Competition by Players/Manufacturers
        2.1.1 EMEA Ophthalmology Drugs Sales Volume and Market Share of Major Players (2012-2017)
        2.1.2 EMEA Ophthalmology Drugs Revenue and Share by Players (2012-2017)
        2.1.3 EMEA Ophthalmology Drugs Sale Price by Players (2012-2017)
    2.2 EMEA Ophthalmology Drugs (Volume and Value) by Type/Product Category
        2.2.1 EMEA Ophthalmology Drugs Sales and Market Share by Type (2012-2017)
        2.2.2 EMEA Ophthalmology Drugs Revenue and Market Share by Type (2012-2017)
        2.2.3 EMEA Ophthalmology Drugs Sale Price by Type (2012-2017)
    2.3 EMEA Ophthalmology Drugs (Volume) by Application
    2.4 EMEA Ophthalmology Drugs (Volume and Value) by Region
        2.4.1 EMEA Ophthalmology Drugs Sales and Market Share by Region (2012-2017)
        2.4.2 EMEA Ophthalmology Drugs Revenue and Market Share by Region (2012-2017)
        2.4.3 EMEA Ophthalmology Drugs Sales Price by Region (2012-2017)

3 Europe Ophthalmology Drugs (Volume, Value and Sales Price), by Players, Countries, Type and Application
    3.1 Europe Ophthalmology Drugs Sales and Value (2012-2017)
        3.1.1 Europe Ophthalmology Drugs Sales Volume and Growth Rate (2012-2017)
        3.1.2 Europe Ophthalmology Drugs Revenue and Growth Rate (2012-2017)
    3.2 Europe Ophthalmology Drugs Sales and Market Share by Type
    3.3 Europe Ophthalmology Drugs Sales and Market Share by Application
    3.4 Europe Ophthalmology Drugs Sales Volume and Value (Revenue) by Countries
        3.4.1 Europe Ophthalmology Drugs Sales Volume by Countries (2012-2017)
        3.4.2 Europe Ophthalmology Drugs Revenue by Countries (2012-2017)
        3.4.3 Germany Ophthalmology Drugs Sales and Growth Rate (2012-2017)
        3.4.4 France Ophthalmology Drugs Sales and Growth Rate (2012-2017)
        3.4.5 UK Ophthalmology Drugs Sales and Growth Rate (2012-2017)
        3.4.6 Russia Ophthalmology Drugs Sales and Growth Rate (2012-2017)
        3.4.7 Italy Ophthalmology Drugs Sales and Growth Rate (2012-2017)
        3.4.8 Benelux Ophthalmology Drugs Sales and Growth Rate (2012-2017)

4 Middle East Ophthalmology Drugs (Volume, Value and Sales Price), by Region, Type and Application
    4.1 Middle East Ophthalmology Drugs Sales and Value (2012-2017)
        4.1.1 Middle East Ophthalmology Drugs Sales Volume and Growth Rate (2012-2017)
        4.1.2 Middle East Ophthalmology Drugs Revenue and Growth Rate (2012-2017)
    4.2 Middle East Ophthalmology Drugs Sales and Market Share by Type
    4.3 Middle East Ophthalmology Drugs Sales and Market Share by Application
    4.4 Middle East Ophthalmology Drugs Sales Volume and Value (Revenue) by Countries
        4.4.1 Middle East Ophthalmology Drugs Sales Volume by Countries (2012-2017)
        4.4.2 Middle East Ophthalmology Drugs Revenue by Countries (2012-2017)
        4.4.3 Saudi Arabia Ophthalmology Drugs Sales and Growth Rate (2012-2017)
        4.4.4 Israel Ophthalmology Drugs Sales and Growth Rate (2012-2017)
        4.4.5 UAE Ophthalmology Drugs Sales and Growth Rate (2012-2017)
        4.4.6 Iran Ophthalmology Drugs Sales and Growth Rate (2012-2017)

5 Africa Ophthalmology Drugs (Volume, Value and Sales Price) by Players, Countries, Type and Application
    5.1 Africa Ophthalmology Drugs Sales and Value (2012-2017)
        5.1.1 Africa Ophthalmology Drugs Sales Volume and Growth Rate (2012-2017)
        5.1.2 Africa Ophthalmology Drugs Revenue and Growth Rate (2012-2017)
    5.2 Africa Ophthalmology Drugs Sales and Market Share by Type
    5.3 Africa Ophthalmology Drugs Sales and Market Share by Application
    5.4 Africa Ophthalmology Drugs Sales Volume and Value (Revenue) by Countries
        5.4.1 Africa Ophthalmology Drugs Sales Volume by Countries (2012-2017)
        5.4.2 Africa Ophthalmology Drugs Revenue by Countries (2012-2017)
        5.4.3 South Africa Ophthalmology Drugs Sales and Growth Rate (2012-2017)
        5.4.4 Nigeria Ophthalmology Drugs Sales and Growth Rate (2012-2017)
        5.4.5 Egypt Ophthalmology Drugs Sales and Growth Rate (2012-2017)
        5.4.6 Algeria Ophthalmology Drugs Sales and Growth Rate (2012-2017)

6 EMEA Ophthalmology Drugs Manufacturers/Players Profiles and Sales Data
    6.1 Novartis
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Ophthalmology Drugs Product Type, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Novartis Ophthalmology Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Regeneron
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Ophthalmology Drugs Product Type, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Regeneron Ophthalmology Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Roche
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Ophthalmology Drugs Product Type, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Roche Ophthalmology Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Bayer
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Ophthalmology Drugs Product Type, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Bayer Ophthalmology Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Allergan
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Ophthalmology Drugs Product Type, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Allergan Ophthalmology Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Shire
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Ophthalmology Drugs Product Type, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Shire Ophthalmology Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Mallinckrodt
        6.7.1 Company Basic Information, Manufacturing Base and Competitors
        6.7.2 Ophthalmology Drugs Product Type, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Mallinckrodt Ophthalmology Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    ...

7 Ophthalmology Drugs Manufacturing Cost Analysis
    7.1 Ophthalmology Drugs Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Ophthalmology Drugs

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Ophthalmology Drugs Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Ophthalmology Drugs Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 EMEA Ophthalmology Drugs Market Forecast (2017-2022)
    11.1 EMEA Ophthalmology Drugs Sales, Revenue and Price Forecast (2017-2022)
        11.1.1 EMEA Ophthalmology Drugs Sales and Growth Rate Forecast (2017-2022)
        11.1.2 EMEA Ophthalmology Drugs Revenue and Growth Rate Forecast (2017-2022)
        11.1.3 EMEA Ophthalmology Drugs Price and Trend Forecast (2017-2022)
    11.2 EMEA Ophthalmology Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.3 Europe Ophthalmology Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.4 Middle Eastt Ophthalmology Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.5 Africa Ophthalmology Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.6 EMEA Ophthalmology Drugs Sales Forecast by Type (2017-2022)
    11.7 EMEA Ophthalmology Drugs Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer

List of Tables and Figures

    Figure Product Picture of Ophthalmology Drugs
    Figure EMEA Ophthalmology Drugs Sales Volume (K Pcs) by Type (2012-2022)
    Figure EMEA Ophthalmology Drugs Sales Volume Market Share by Type (Product Category) in 2016
    Figure Lucentis (ranibizumab) Product Picture
    Figure Eylea (aflibercept) Product Picture
    Figure Avastin (bevacizumab) Product Picture
    Figure Restasis (cyclosporine) Product Picture
    Figure Alphagan (brimonidine tartrate) Product Picture
    Figure Lumigan (bimatoprost) Product Picture
    Figure Xalatan (latanoprost Product Picture
    Figure EMEA Ophthalmology Drugs Sales Volume (K Pcs) by Application (2012-2022)
    Figure EMEA Sales Market Share of Ophthalmology Drugs by Application in 2016
    Figure Chorioretinitis Examples
    Table Key Downstream Customer in Chorioretinitis
    Figure Choroiditis Examples
    Table Key Downstream Customer in Choroiditis
    Figure Retinitis Examples
    Table Key Downstream Customer in Retinitis
    Figure Others Examples
    Table Key Downstream Customer in Others
    Figure EMEA Ophthalmology Drugs Market Size (Million USD) by Region (2012-2022)
    Figure Europe Ophthalmology Drugs Revenue (Million USD) and Growth Rate (2012-2022)
    Figure Europe Ophthalmology Drugs Revenue (Million USD) Status and Forecast by Countries
    Figure Middle East Ophthalmology Drugs Revenue (Million USD) and Growth Rate (2012-2022)
    Figure Middle East Ophthalmology Drugs Revenue (Million USD) Status and Forecast by Countries
    Figure Africa Ophthalmology Drugs Revenue (Million USD) and Growth Rate (2012-2022)
    Figure Africa Ophthalmology Drugs Revenue (Million USD) Status and Forecast by Countries
    Figure EMEA Ophthalmology Drugs Sales Volume and Growth Rate (2012-2022)
    Figure EMEA Ophthalmology Drugs Revenue (Million USD) and Growth Rate (2012-2022)
    Figure EMEA Ophthalmology Drugs Market Major Players Product Sales Volume (K Pcs) (2012-2017)
    Table EMEA Ophthalmology Drugs Sales Volume (K Pcs) of Major Players (2012-2017)
    Table EMEA Ophthalmology Drugs Sales Share by Players (2012-2017)
    Figure 2016 Ophthalmology Drugs Sales Share by Players
    Figure 2017 Ophthalmology Drugs Sales Share by Players
    Figure EMEA Ophthalmology Drugs Market Major Players Product Revenue (Million USD) (2012-2017)
    Table EMEA Ophthalmology Drugs Revenue (Million USD) by Players (2012-2017)
    Table EMEA Ophthalmology Drugs Revenue Share by Players (2012-2017)
    Table 2016 EMEA Ophthalmology Drugs Revenue Share by Players
    Table 2017 EMEA Ophthalmology Drugs Revenue Share by Players
    Table EMEA Ophthalmology Drugs Sale Price (USD/Pcs) by Players (2012-2017)
    Table EMEA Ophthalmology Drugs Sales (K Pcs) and Market Share by Type (2012-2017)
    Table EMEA Ophthalmology Drugs Sales Share by Type (2012-2017)
    Figure Sales Market Share of Ophthalmology Drugs by Type (2012-2017)
    Figure EMEA Ophthalmology Drugs Sales Market Share by Type (2012-2017)
    Table EMEA Ophthalmology Drugs Revenue (Million USD) and Market Share by Type (2012-2017)
    Table EMEA Ophthalmology Drugs Revenue Share by Type (2012-2017)
    Figure Revenue Market Share of Ophthalmology Drugs by Type in 2016
    Table EMEA Ophthalmology Drugs Sale Price (USD/Pcs) by Type (2012-2017)
    Table EMEA Ophthalmology Drugs Sales (K Pcs) and Market Share by Application (2012-2017)
    Table EMEA Ophthalmology Drugs Sales Share by Application (2012-2017)
    Figure Sales Market Share of Ophthalmology Drugs by Application (2012-2017)
    Figure EMEA Ophthalmology Drugs Sales Market Share by Application in 2016
    Table EMEA Ophthalmology Drugs Sales (K Pcs) and Market Share by Region (2012-2017)
    Table EMEA Ophthalmology Drugs Sales Share by Region (2012-2017)
    Figure Sales Market Share of Ophthalmology Drugs by Region (2012-2017)
    Figure EMEA Ophthalmology Drugs Sales Market Share in 2016
    Table EMEA Ophthalmology Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
    Table EMEA Ophthalmology Drugs Revenue Share by Region (2012-2017)
    Figure Revenue Market Share of Ophthalmology Drugs by Region (2012-2017)
    Figure EMEA Ophthalmology Drugs Revenue Market Share Regions in 2016
    Table EMEA Ophthalmology Drugs Sales Price (USD/Pcs) by Region (2012-2017)
    Figure Europe Ophthalmology Drugs Sales (K Pcs) and Growth Rate (2012-2017)
    Figure Europe Ophthalmology Drugs Revenue and Growth Rate (2012-2017)
    Table Europe Ophthalmology Drugs Sales (K Pcs) by Type (2012-2017)
    Table Europe Ophthalmology Drugs Market Share by Type (2012-2017)
    Figure Europe Ophthalmology Drugs Market Share by Type in 2016
    Table Europe Ophthalmology Drugs Sales (K Pcs) by Application (2012-2017)
    Table Europe Ophthalmology Drugs Market Share by Application (2012-2017)
    Figure Europe Ophthalmology Drugs Market Share by Application in 2016
    Table Europe Ophthalmology Drugs Sales (K Pcs) by Countries (2012-2017)
    Table Europe Ophthalmology Drugs Sales Market Share by Countries (2012-2017)
    Figure Europe Ophthalmology Drugs Sales Market Share by Countries (2012-2017)
    Figure Europe Ophthalmology Drugs Sales Market Share by Countries in 2016
    Table Europe Ophthalmology Drugs Revenue (Million USD) by Countries (2012-2017)
    Table Europe Ophthalmology Drugs Revenue Market Share by Countries (2012-2017)
    Figure Europe Ophthalmology Drugs Revenue Market Share by Countries (2012-2017)
    Figure Europe Ophthalmology Drugs Revenue Market Share by Countries in 2016
    Figure Germany Ophthalmology Drugs Sales (K Pcs) and Growth Rate (2012-2017)
    Figure France Ophthalmology Drugs Sales (K Pcs) and Growth Rate (2012-2017)
    Figure UK Ophthalmology Drugs Sales (K Pcs) and Growth Rate (2012-2017)
    Figure Russia Ophthalmology Drugs Sales (K Pcs) and Growth Rate (2012-2017)
    Figure Italy Ophthalmology Drugs Sales (K Pcs) and Growth Rate (2012-2017)
    Figure Benelux Ophthalmology Drugs Sales (K Pcs) and Growth Rate (2012-2017)
    Figure Middle East Ophthalmology Drugs Sales (K Pcs) and Growth Rate (2012-2017)
    Figure Middle East Ophthalmology Drugs Revenue (Million USD) and Growth Rate (2012-2017)
    Table Middle East Ophthalmology Drugs Sales (K Pcs) by Type (2012-2017)
    Table Middle East Ophthalmology Drugs Market Share by Type (2012-2017)
    Figure Middle East Ophthalmology Drugs Market Share by Type (2012-2017)
    Table Middle East Ophthalmology Drugs Sales (K Pcs) by Applications (2012-2017)
    Table Middle East Ophthalmology Drugs Market Share by Applications (2012-2017)
    Figure Middle East Ophthalmology Drugs Sales Market Share by Application in 2016
    Table Middle East Ophthalmology Drugs Sales Volume (K Pcs) by Countries (2012-2017)
    Table Middle East Ophthalmology Drugs Sales Volume Market Share by Countries (2012-2017)
    Figure Middle East Ophthalmology Drugs Sales Volume Market Share by Countries in 2016
    Table Middle East Ophthalmology Drugs Revenue (Million USD) by Countries (2012-2017)
    Table Middle East Ophthalmology Drugs Revenue Market Share by Countries (2012-2017)
    Figure Middle East Ophthalmology Drugs Revenue Market Share by Countries (2012-2017)
    Figure Middle East Ophthalmology Drugs Revenue Market Share by Countries in 2016
    Figure Saudi Arabia Ophthalmology Drugs Sales (K Pcs) and Growth Rate (2012-2017)
    Figure Israel Ophthalmology Drugs Sales (K Pcs) and Growth Rate (2012-2017)
    Figure UAE Ophthalmology Drugs Sales (K Pcs) and Growth Rate (2012-2017)
    Figure Iran Ophthalmology Drugs Sales (K Pcs) and Growth Rate (2012-2017)
    Figure Africa Ophthalmology Drugs Sales (K Pcs) and Growth Rate (2012-2017)
    Figure Africa Ophthalmology Drugs Revenue (Million USD) and Growth Rate (2012-2017)
    Table Africa Ophthalmology Drugs Sales (K Pcs) by Type (2012-2017)
    Table Africa Ophthalmology Drugs Sales Market Share by Type (2012-2017)
    Figure Africa Ophthalmology Drugs Sales Market Share by Type (2012-2017)
    Figure Africa Ophthalmology Drugs Sales Market Share by Type in 2016
    Table Africa Ophthalmology Drugs Sales (K Pcs) by Application (2012-2017)
    Table Africa Ophthalmology Drugs Sales Market Share by Application (2012-2017)
    Figure Africa Ophthalmology Drugs Sales Market Share by Application (2012-2017)
    Table Africa Ophthalmology Drugs Sales Volume (K Pcs) by Countries (2012-2017)
    Table Africa Ophthalmology Drugs Sales Market Share by Countries (2012-2017)
    Figure Africa Ophthalmology Drugs Sales Market Share by Countries (2012-2017)
    Figure Africa Ophthalmology Drugs Sales Market Share by Countries in 2016
    Table Africa Ophthalmology Drugs Revenue (Million USD) by Countries (2012-2017)
    Table Africa Ophthalmology Drugs Revenue Market Share by Countries (2012-2017)
    Figure Africa Ophthalmology Drugs Revenue Market Share by Countries (2012-2017)
    Figure Africa Ophthalmology Drugs Revenue Market Share by Countries in 2016
    Figure South Africa Ophthalmology Drugs Sales (K Pcs) and Growth Rate (2012-2017)
    Figure Nigeria Ophthalmology Drugs Sales (K Pcs) and Growth Rate (2012-2017)
    Figure Egypt Ophthalmology Drugs Sales (K Pcs) and Growth Rate (2012-2017)
    Figure Algeria Ophthalmology Drugs Sales (K Pcs) and Growth Rate (2012-2017)
    Table Novartis Ophthalmology Drugs Basic Information List
    Table Novartis Ophthalmology Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
    Figure Novartis Ophthalmology Drugs Sales (K Pcs) and Growth Rate (2012-2017)
    Figure Novartis Ophthalmology Drugs Sales Market Share in EMEA (2012-2017)
    Figure Novartis Ophthalmology Drugs Revenue Market Share in EMEA (2012-2017)
    Table Regeneron Ophthalmology Drugs Basic Information List
    Table Regeneron Ophthalmology Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
    Figure Regeneron Ophthalmology Drugs Sales (K Pcs) and Growth Rate (2012-2017)
    Figure Regeneron Ophthalmology Drugs Sales Market Share in EMEA (2012-2017)
    Figure Regeneron Ophthalmology Drugs Revenue Market Share in EMEA (2012-2017)
    Table Roche Ophthalmology Drugs Basic Information List
    Table Roche Ophthalmology Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
    Figure Roche Ophthalmology Drugs Sales (K Pcs) and Growth Rate (2012-2017)
    Figure Roche Ophthalmology Drugs Sales Market Share in EMEA (2012-2017)
    Figure Roche Ophthalmology Drugs Revenue Market Share in EMEA (2012-2017)
    Table Bayer Ophthalmology Drugs Basic Information List
    Table Bayer Ophthalmology Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
    Figure Bayer Ophthalmology Drugs Sales (K Pcs) and Growth Rate (2012-2017)
    Figure Bayer Ophthalmology Drugs Sales Market Share in EMEA (2012-2017)
    Figure Bayer Ophthalmology Drugs Revenue Market Share in EMEA (2012-2017)
    Table Allergan Ophthalmology Drugs Basic Information List
    Table Allergan Ophthalmology Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
    Figure Allergan Ophthalmology Drugs Sales (K Pcs) and Growth Rate (2012-2017)
    Figure Allergan Ophthalmology Drugs Sales Market Share in EMEA (2012-2017)
    Figure Allergan Ophthalmology Drugs Revenue Market Share in EMEA (2012-2017)
    Table Shire Ophthalmology Drugs Basic Information List
    Table Shire Ophthalmology Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
    Figure Shire Ophthalmology Drugs Sales (K Pcs) and Growth Rate (2012-2017)
    Figure Shire Ophthalmology Drugs Sales Market Share in EMEA (2012-2017)
    Figure Shire Ophthalmology Drugs Revenue Market Share in EMEA (2012-2017)
    Table Mallinckrodt Ophthalmology Drugs Basic Information List
    Table Mallinckrodt Ophthalmology Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
    Figure Mallinckrodt Ophthalmology Drugs Sales (K Pcs) and Growth Rate (2012-2017)
    Figure Mallinckrodt Ophthalmology Drugs Sales Market Share in EMEA (2012-2017)
    Figure Mallinckrodt Ophthalmology Drugs Revenue Market Share in EMEA (2012-2017)
    Table Production Base and Market Concentration Rate of Raw Material
    Figure Price Trend of Key Raw Materials
    Table Key Suppliers of Raw Materials
    Figure Manufacturing Cost Structure of Ophthalmology Drugs
    Figure Manufacturing Process Analysis of Ophthalmology Drugs
    Figure Ophthalmology Drugs Industrial Chain Analysis
    Table Raw Materials Sources of Ophthalmology Drugs Major Manufacturers in 2016
    Table Major Buyers of Ophthalmology Drugs
    Table Distributors/Traders List
    Figure EMEA Ophthalmology Drugs Sales (K Pcs) and Growth Rate Forecast (2017-2022)
    Figure EMEA Ophthalmology Drugs Revenue and Growth Rate Forecast (2017-2022)
    Figure EMEA Ophthalmology Drugs Price (USD/Pcs) and Trend Forecast (2017-2022)
    Table EMEA Ophthalmology Drugs Sales (K Pcs) Forecast by Region (2017-2022)
    Figure EMEA Ophthalmology Drugs Sales Market Share Forecast by Region (2017-2022)
    Table EMEA Ophthalmology Drugs Revenue (Million USD) Forecast by Region (2017-2022)
    Figure EMEA Ophthalmology Drugs Revenue Market Share Forecast by Region (2017-2022)
    Table Europe Ophthalmology Drugs Sales (K Pcs) Forecast by Countries (2017-2022)
    Figure Europe Ophthalmology Drugs Sales Market Share Forecast by Countries (2017-2022)
    Table Europe Ophthalmology Drugs Revenue (Million USD) Forecast by Countries (2017-2022)
    Figure Europe Ophthalmology Drugs Revenue Market Share Forecast by Countries (2017-2022)
    Table Middle East Ophthalmology Drugs Sales (K Pcs) Forecast by Countries (2017-2022)
    Figure Middle East Ophthalmology Drugs Sales Market Share Forecast by Countries (2017-2022)
    Table Middle East Ophthalmology Drugs Revenue (Million USD) Forecast by Countries (2017-2022)
    Figure Middle East Ophthalmology Drugs Revenue Market Share Forecast by Countries (2017-2022)
    Table Africa Ophthalmology Drugs Sales (K Pcs) Forecast by Countries (2017-2022)
    Figure Africa Ophthalmology Drugs Sales Market Share Forecast by Countries (2017-2022)
    Table Africa Ophthalmology Drugs Revenue (Million USD) Forecast by Countries (2017-2022)
    Figure Africa Ophthalmology Drugs Revenue Market Share Forecast by Countries (2017-2022)
    Table EMEA Ophthalmology Drugs Sales (K Pcs) Forecast by Type (2017-2022)
    Figure EMEA Ophthalmology Drugs Sales Market Share Forecast by Type (2017-2022)
    Table EMEA Ophthalmology Drugs Sales (K Pcs) Forecast by Application (2017-2022)
    Figure EMEA Ophthalmology Drugs Sales Market Share Forecast by Application (2017-2022)
    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Table Key Data Information from Secondary Sources
    Table Key Data Information from Primary Sources